Leading the Fight to treat and cure
Tay-Sachs, Canavan, Sandhoff, GM1 and related diseases

History of Tay-Sachs Disease

Warren Tay

The disease is named for Warren Tay (1843-1927), a British ophthalmologist who in 1881 described a patient with a cherry-red spot on the retina of the eye.

Bernard Sachs

It is also named for Bernard Sachs (1858-1944), a New York neurologist whose work several years later provided the first description of the cellular changes in Tay-Sachs disease. Dr. Sachs also recognized the familial nature of the disorder, and, by observing numerous cases, he noted that most babies with Tay-Sachs disease at that time were of Eastern European Jewish origin. Today, Tay-Sachs occurs among people of all backgrounds.

HexA Deficiency Discoverd

In August 1969, Dr. Shintaro Okada and Dr. John S. O'Brien published the discovery of the Hexosaminidase A deficiency in Tay-Sachs. Nearly two years later in May 1971 the first Tay-Sachs community screning event took place in Bethesda, Maryland.

Gene Identity

The gene that causes Tay-Sachs was identified in the late 1980's and by the mid-1990's, over 75 different mutations had been identified. Currently there are over 100 mutations reported from all ethnic groups.


Enter your email to receive NTSAD's Topic of the Week or quarterly news.